Lipid droplets: A new player in colorectal cancer stem cells unveiled by spectroscopic imaging

Stem Cells

Volumn 33, Issue 1, 2015, Pages 35-44

  Tirinato, Luca ^a,b   Liberale, Carlo ^a,c   Di Franco, Simone ^d,e   Candeloro, Patrizio ^b   Benfante, Antonina ^d   La Rocca, Rosanna ^c   Potze, Lisette ^e   Marotta, Roberto ^c   Ruffilli, Roberta ^c   Rajamanickam, Vijayakumar P ^a,c   Malerba, Mario ^c   De Angelis, Francesco ^c   Falqui, Andrea ^a,c   Carbone, Ennio ^b,f   Todaro, Matilde ^d   Medema, Jan Paul ^e   Stassi, Giorgio ^d   Di Fabrizio, Enzo ^a,b  

^a KING ABDULLAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Saudi Arabia)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Colorectal cancer stem cells; Lipid droplets; Raman spectroscopy; Wnt catenin pathway

Indexed keywords

CD133 ANTIGEN; FAT DROPLET; WNT PROTEIN; TUMOR MARKER;

ANIMAL EXPERIMENT; ARTICLE; CANCER RECURRENCE; CANCER STEM CELL; CARCINOGENIC ACTIVITY; COLORECTAL CANCER; CONFOCAL MICROSCOPY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; RAMAN SPECTROMETRY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VOLUME; WNT SIGNALING PATHWAY; XENOTRANSPLANTATION; ANIMAL; COLORECTAL TUMOR; HUMAN; METABOLISM; PATHOLOGY; PROCEDURES;

ANIMALS; BIOMARKERS, TUMOR; COLORECTAL NEOPLASMS; HUMANS; LIPID DROPLETS; MICE; NEOPLASTIC STEM CELLS; SPECTRUM ANALYSIS, RAMAN; WNT SIGNALING PATHWAY;

EID: 84919429576     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1837     Document Type: Article

References (60)

1. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-130.
2. Schwitalla S, Fingerle AA, Cammareri P, et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-cell-like properties. Cell 2013; 152: 25-38.
3. Barker N, van Es JH, Kuipers J, et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007; 449: 1003-1007.
4. Sneddon JB, Werb Z,. Location, location, location: The cancer stem cell niche. Cell Stem Cell 2007; 1: 607-611.
5. Visvader J,. Cells of origin in cancer. Nature 2011; 469: 314-322.
6. Vermeulen L, De Sousa E Melo, van der Heijden M, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010; 12: 468-476.
7. Prasetyanti PR, Zimberlin CD, Bots M, et al. Regulation of stem cell self-renewal and differentiation by Wnt and Notch are conserved throughout the adenoma-carcinoma sequence in the colon. Mol Cancer 2013; 12.
8. Dieter SM, Ball CR, Hoffmann CM, et al. Distinct types of tumor-initiating cells form human colon cancer tumors and metastases. Cell Stem Cell 2011; 9: 357-365.
9. Todaro M,. Colon cancer stem cells: Promise of targeted therapy. Gastroenterology 2010; 138: 2151-2162.
10. Todaro M, Alea Mileidys Perez, Di Stefano AB, et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. Cell Stem Cell 2007; 1: 389-402.
11. Clarke MF, Fuller M,. Stem cells and cancer: Two faces of eve. Cell 2006; 124: 1111-1115.
12. Lathia J, Venere M, Rao M, et al. Seeing is believing: Are cancer stem cells the Loch Ness monster of tumor biology? Stem Cell Rev Rep 2011; 7: 227-237.
13. Shackleton M, Quintana E, Fearon ER, et al. Heterogeneity in cancer: Cancer stem cells versus clonal evolution. Cell 2009; 138: 822-829.
14. Medema JP,. Cancer stem cells: The challenges ahead. Nat Cell Biol 2013; 15: 338-344.
15. Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells-Perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res 2006; 66: 9339-9344.
16. Ladman AJ, Martinez AO,. Cell contacts and surface-features of 3 murine tumors grown as multicellular spheroids. Eur J Cell Biol 1988; 45: 224-229.
17. O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-110.
18. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115.
19. Dalerba P, Dylla SJ, Park IK, et al. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104: 10158-10163.
20. Glazer RI, Vo DT, Penalva LOF,. Musashi1: An RBP with versatile functions in normal and cancer stem cells. Front Biosci (Landmark Ed) 2012; 17: 54-64.
21. Schepers AG, Snippert HJ, Stange DE, et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012; 337: 730-735.
22. De Angelis F, Das G, Candeloro P, et al. Nanoscale chemical mapping using three-dimensional adiabatic compression of surface plasmon polaritons. Nat Nanotechnol 2011; 5: 67-72.
23. De Angelis F, Gentile F, Mecarini F, et al. Breaking the diffusion limit with super-hydrophobic delivery of molecules to plasmonic nanofocusing SERS structures. Nat Photon 2011; 5: 683-688.
24. Cottat M, Thioune N, Gabudean AM, et al. Localized surface plasmon resonance (LSPR) biosensor for the protein detection. Plasmonics 2013; 8: 699-704.
25. Das G, La Rocca R, Lakshmikanth T, et al. Monitoring human leukocyte antigen class I molecules by micro-Raman spectroscopy at single-cell level. J Biomed Opt 2010; 15: 027007.
26. Uzunbajakava N, Lenferink A, Kraan Y, et al. Nonresonant confocal Raman imaging of DNA and protein distribution in apoptotic cells. Biophys J 2003; 84: 3968-3981.
27. Matthaeus C, Kale A, Chernenko T, et al. New ways of imaging uptake and intracellular fate of liposomal drug carrier systems inside individual cells, based on Raman microscopy. Mol Pharm 2008; 5: 287-293.
28. Matthaus C, Chernenko T, Tatyana N, et al. Label-free detection of mitochondrial distribution in cells by nonresonant Raman microspectroscopy. Biophys J 2007; 93: 668-673.
29. van Manen HJ, Kraan YM, Roos D, et al. Single-cell Raman and fluorescence microscopy reveal the association of lipid bodies with phagosomes in leukocytes. Proc Natl Acad Sci USA 2005; 102: 10159-10164.
30. Freudiger CW, Min W, Saar BG, et al. Label-free biomedical imaging with high sensitivity by stimulated Raman scattering microscopy. Science 2008; 322: 1857-1861.
31. Listenberger LL, Brown DA,. Fluorescent detection of lipid droplets and associated proteins. In:, Juan S,., Bonifacino, et al., eds. Current Protocols in Cell Biology/Editorial Board. Chapter 24, 2007:Unit 24 2.
32. Spandl J, White DJ, Peychl J, et al. Live cell multicolor imaging of lipid droplets with a new dye, LD540. Traffic 2009; 10: 1579-1584.
33. Hu YF, Smyth GK,. ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 2009; 347: 70-78.
34. Chan JW, Motton D, Rutledge JC, et al. Raman spectroscopic analysis of biochemical changes in individual triglyceride-rich lipoproteins in the pre- and postprandial state. Anal Chem 2005; 77: 5870-5876.
35. Wu H, Volponi JV, Oliver AE, et al. In vivo lipidomics using single-cell Raman spectroscopy. Proc Natl Acad Sci USA 2011; 108: 3809-3814.
36. Candeloro P, Grande E, Raimondo R, et al. Raman database of amino acids solutions: A critical study of extended multiplicative signal correction. Analyst 2013; 138: 7331-7340.
37. Martin S, Parton RG,. Lipid droplets: A unified view of a dynamic organelle. Nat Rev Mol Cell Biol 2006; 7: 373-378.
38. Goodman JM,. Demonstrated and inferred metabolism associated with cytosolic lipid droplets. J Lipid Res 2009; 50: 2148-2156.
39. Schneider CA, Rasband WS, Eliceiri KW,. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012; 9: 671-675.
40. Dees JH, Gazouli M, Papadopoulos V,. Effect of mono-ethylhexyl phthalate on MA-10 Leydig tumor cells. Reprod Toxicol 2001; 15: 171-187.
41. Bozza PT, Viola JPB,. Lipid droplets in inflammation and cancer. Prostaglandins Leukot Essent Fatty Acids 2010; 82: 243-250.
42. Farese RV, Jr., Walther TC., Lipid droplets finally get a little R-E-S-P-E-C-T. Cell 2009; 139: 855-860.
43. Accioly MT, Pacheco P, Maya-Monteiro CM, et al. Lipid bodies are reservoirs of cyclooxygenase-2 and sites of prostaglandin-E-2 synthesis in colon cancer cells. Cancer Res 2008; 68: 1732-1740.
44. Mutoh M, Komiya M, Teraoka N, et al. Overexpression of low-density lipoprotein receptor and lipid accumulation in intestinal polyps in Min mice. Int J Cancer 2009; 125: 2505-2510.
45. Eberhart CE, Coffey RJ, Radhika A, et al. Up-regulation of cyclooxygenase-2 gene-expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183-1188.
46. Kargman SL, Oneill GP, Vickers PJ, et al. Expression of prostaglandin G/H synthase-1 and synthase-2 protein in human colon-cancer. Cancer Res 1995; 55: 2556-2559.
47. Sano H, Kawahito Y, Wilder RL, et al. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human colorectal-cancer. Cancer Res 1995; 55: 3785-3789.
48. Fujimoto T, Kogo H, Ishiguro K, et al. Caevolin-2 is targeted to lipid droplets, a new "membrane domain" in the cell. J Cell Biol 2001; 152: 1079-1085.
49. Pol A, Luetterforst R, Lindsay M, et al. A caveolin dominant negative mutant associates with lipid bodies and induces intracellular cholesterol imbalance. J Cell Biol 2001; 152: 1057-1070.
50. Yu W, Cassara J, Weller PF,. Phosphatidylinositide 3-kinase localizes to cytoplasmic lipid bodies in human polymorphonuclear leukocytes and other myeloid-derived cells. Blood 2000; 95: 1078-1085.
51. Matsubara J, Honda K, Ono M, et al. Identification of adipophilin as a potential plasma biomarker for colorectal cancer using label-free quantitative mass spectrometry and protein microarray. Cancer Epidemiol Biomarkers Prev 2011; 20: 2195-2203.
52. Thun MJ, Henley SJ, Patrono C,. Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 2002; 94: 252-266.
53. Thun MJ, Jacobs EJ, Patrono C,. The role of aspirin in cancer prevention. Nature reviews. Clin Oncol 2012; 9: 259-267.
54. Ali R, Toh HC, Chia WK, et al. The utility of Aspirin in dukes C and high risk dukes B colorectal cancer-The ASCOLT study: Study protocol for a randomized controlled trial. Trials 2011; 12: 261.
55. Ito K, Suda T,. Metabolic requirements for the maintenance of self-renewing stem cells. Nat Rev Mol Cell Biol 2014; 15: 243-256.
56. Sorrentino G, Ruggeri N, Specchia V, et al. Metabolic control of YAP and TAZ by the mevalonate pathway. Nat Cell Biol 2014; 16: 357-366.
57. Francescangeli F, Patrizii M, Signore M, et al. Proliferation state and polo-like kinase1 dependence of tumorigenic colon cancer cells. Stem Cells 2012; 30: 1819-1830.
58. Santos CR, Schulze A,. Lipid metabolism in cancer. FEBS J 2012; 279: 2610-2623.
59. Ji MB, Orringer DA, Freudiger CW, et al. Rapid, label-free detection of brain tumors with stimulated raman scattering microscopy. Sci Transl Med 2013; 5.
60. Saar BG, Johnston RS, Freudiger CW, et al. Coherent Raman scanning fiber endoscopy. Opt Lett 2011; 36: 2396-2398.